Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

crjmed. 2024; 3(1): 31-36


Outcome and Quality of Life in a Patient with Advanced Multiple Myeloma in Whom Blood Transfusion Is Not an Option: A Case Report

Marcus I. Asuquo, Kenneth O. Inaku, Nathaniel I. Usoro, Kingsley O. Akaba.




Abstract

Background: Patients with multiple myeloma often experience severe anaemia, complicating management, especially when they object to blood transfusion due to religious beliefs.
Objective: To present a successful management approach for severe anaemia in a patient with multiple myeloma who refused blood transfusion.
Methods: We present a case of a 58-year-old male patient with multiple myeloma who objected to blood transfusion due to his religious beliefs. The presenting haemoglobin level ( Hb) was 2.5g/dl, with signs and symptoms of heart failure and hyperviscosity syndrome. We resuscitated the patient and commenced Hb optimisation using intravenous iron, intravenous vitamin C, intravenous Vitamin B complex, and subcutaneous human recombinant erythropoietin Beta.
Results: The patient progressed from a wheelchair to independent walking, achieved remission, and saw haemoglobin rise to 8 g/dL. Stable blood pressure and PCV (30-35%) indicated successful management.
Conclusion: It is possible to manage very severe anaemia without blood transfusion in patients with multiple myeloma. We recommend clinical trials on managing anaemia without blood transfusion in multiple myeloma patients. This strategy will benefit many patients who need treatment in settings where transfusion is not possible and especially where blood transfusion is not an option.

Key words: Multiple Myeloma, Quality of Life, Blood transfusion, Anaemia






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.